Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone PCA for pain management in acute pancreatitis
ChiCTR1900025971Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of hydromorphone in acute pancreatitis (AP) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Visual Analog Scale and Area Under the Pain Curve. Started Jun 2019; status: recruiting.
02
Drugs
hydromorphone
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on ChiCTR1900025971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025971.